PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
Cancer Cell2004Vol. 6(2), pp. 117–127
Citations Over TimeTop 1% of 2004 papers
Yoichi Nagata, Keng‐Hsueh Lan, Xiaoyan Zhou, Ming Tan, Francisco J. Esteva, Ayşegül A. Şahin, Kristine S. Klos, Ping Li, Brett P. Monia, Nina Nguyen, Gabriel N. Hortobágyi, Mien‐Chie Hung, Dihua Yu
Related Papers
- → PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells is mediated by p27kip1(2000)145 cited
- → Roles of PTEN inactivation and PD-1/PD-L1 activation in esophageal squamous cell carcinoma(2022)9 cited
- → Genetic profile, PTEN mutation and therapeutic role of PTEN in glioblastomas(2002)31 cited
- → RETRACTED ARTICLE: Inhibited MicroRNA-301 Restrains Angiogenesis and Cell Growth in Esophageal Squamous Cell Carcinoma by Elevating PTEN(2021)5 cited